Blood product usage



blood product usage


Over the past two decades, researchers have emphasised both the positive and negative effects of blood product usage and highlighted the importance of the identification and management of anaemia. We now have a clearer, although not complete, understanding of rational and appropriate blood product usage, with several guidelines and changes in the strategies for blood product administration. This shift in thinking has included the introduction of ‘Patient Blood Management’ (PBM) – the application of evidence-based practices to optimise patient outcomes by managing and preserving the patient’s own blood. Recently proposed as a potential solution for the South African context, PBM is particularly relevant considering the high prevalence of anaemia in our population, the severe blood product shortages, dwindling blood donor pool, and high demand for blood products.1 

Author Biographies

R D Wise, University of KwaZulu-Natal

Discipline of Anaesthesia and Critical Care, School of Clinical Medicine, University of KwaZulu-Natal, South Africa and Adult Intensive Care, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, United Kingdom

M Gibbs, University of Cape Town

Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, South Africa